NEAT1 and osteosarcoma: Existing evidence has shown that NEAT1 acts as an oncogene in most types of cancer (non-small cell lung cancer, pancreatic cancer, osteosarcoma, renal cell carcinoma and so on), while in acute promyelocytic leukemia, it functions as a tumor suppressor [39, 40].